Aethlon CEO to Present at Today's Bird Flu Summit
February 27 2006 - 5:00AM
Business Wire
Aethlon Medical, Inc. (OTCBB:AEMD), a pioneer in developing
therapeutic devices for infectious disease, announced that its
Chairman and CEO, James A. Joyce, will give a presentation today at
Washington DC's first Bird Flu Summit. Mr. Joyce's presentation,
The Aethlon Hemopurifier(TM) as a Treatment for Drug Resistant
Avian Flu, will begin at 4pm EST. Full details of the conference
can be accessed online at www.bfsummit.com. About Aethlon Medical
Aethlon Medical is developing the first medical device to treat
infectious disease. The device, known as the Hemopurifier(TM), is a
broad-spectrum treatment countermeasure against drug and vaccine
resistant bioweapons, naturally evolving pandemic threats such as
H5N1 Avian Flu, and chronic infectious disease targets including
Hepatitis-C (HCV) and the Human Immunodeficiency Virus (HIV). More
information on Aethlon Medical and the Hemopurifier(TM) technology
can be found at www.aethlonmedical.com. Certain of the statements
herein may be forward-looking and involve risks and uncertainties.
Such forward-looking statements involve assumptions, known and
unknown risks, uncertainties and other factors which may cause the
actual results, performance or achievements of Aethlon Medical,
Inc. to be materially different from any future results,
performance, or achievements expressed or implied by the
forward-looking statements. Such potential risks and uncertainties
include, without limitation, the Company's ability to raise capital
when needed, the Company's ability to complete the development of
its planned products, the ability of the Company to obtain FDA and
other regulatory approvals permitting the sale of its products, the
Company's ability to manufacture its products and provide its
services, the impact of government regulations, patent protection
on the Company's proprietary technology, product liability
exposure, uncertainty of market acceptance, competition,
technological change, and other risk factors. In such instances,
actual results could differ materially as a result of a variety of
factors, including the risks associated with the effect of changing
economic conditions and other risk factors detailed in the
Company's Securities and Exchange Commission filings.
Atlas Copco (PK) (USOTC:ATLRF)
Historical Stock Chart
From Mar 2024 to Apr 2024
Atlas Copco (PK) (USOTC:ATLRF)
Historical Stock Chart
From Apr 2023 to Apr 2024